Skip to main content

Back to Cancer Australia's website

Australian Government - Cancer Australia
Home

Search form

EdCaN - learning resources for nurses

  • EdCaN learning resources
  • Professional development
  • About EdCaN
  • Contact us

Search form

  • Overview
  • Reduce risk
  • Early detection
  • Active treatment
  • After active treatment
  • References
  1. EdCaN learning resources
  2. Case-based learning resources
  3. Prostate cancer
  4. References
  • Printer-friendly version
  • A|A

References

  • Using the EdCaN resources
  • Case-based learning resources
    • Colorectal cancer
    • Melanoma
    • Head and neck cancer
    • Acute lymphoblastic leukaemia
    • Lung cancer
    • Ovarian cancer
    • Prostate cancer
      • Overview
      • Reduce risk
      • Early detection
      • Active treatment
      • After active treatment
      • References
    • Breast cancer
    • Oesophageal cancer
    • Osteosarcoma
    • Lymphoma
  • Supporting resources
  • Entry to specialty program
  1. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia: an overview, 2010. 2010 [cited Cancer series no. 60, Cat no. CAN 56; Available from: http://www.aihw.gov.au/publication-detail/?id=6442472459.
  2. AIHW & AACR. Cancer in Australia: an overview 2012. 2012; Available from: http://www.aihw.gov.au/publication-detail/?id=60129542359&tab=3.
  3. Australian Institute of Health and Welfare. Cancer survival and prevalence in Australia: period estimates from 1982 to 2010. 2012; Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=10737422721 (PDF, 6.60MB)
  4. Cancer Council Australia. Clinical practice guidelines PSA Testing and Early Management of Test-Detected Prostate Cancer 2015; Available from: http://wiki.cancer.org.au/australia/Guidelines:PSA_Testing#_ga=1.188212392.1240204767.1453861733.
  5. National Health and Medical Research Council. PSA Testing for Prostate Cancer in Asymptomatic Men: Information for Health Practitioners. 2014; Available from: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/men4d_psa_testing_asymptomatic_men_140304.pdf (PDF, 121KB)
  6. Australian Institute of Health and Welfare, Cancer in Australia: an overview 2014. Cancer series no.90. Cat. no. 88. 2014. Available from  http://www.aihw.gov.au/publication-detail/?id=60129550047
  7. Australian Health Ministers' Advisory Council and Cancer Council Australia. Prostate Cancer Screening in Australia: Position Statement. 2014. May 2015; Available from: http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/6E78CE81271972AECA257CEE00028543/$File/Prostate%20Cancer%20Screening%20Position%20Statement.pdf (PDF, 50KB)
  8. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries, Cancer in Australia: an overview, 2006, in Cancer Series Number 37. 2007, Australian Institute of Health and Welfare.
  9. American Urological Association, Prostate-specific antigen best practice statement: 2009 update. 2009.
  10. Australian Institute of Health and Welfare, Cancer Australia, and Australasian Association of Cancer Registries. Cancer survival and prevalence in Australia: cancers diagnosed from 1982-2004. 2008 [cited Cancer series no. 42, Cat no. CAN 38; Available from: http://www.aihw.gov.au/publication-detail/?id=6442468141.
  11. Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality (ACIM) books: Prostate cancer. 2015. April 2015; Available from: https://www.aihw.gov.au/reports/cancer/acim-books/contents/acim-books.
  12. Johns, L.E. and R.S. Houlston, A systematic review and meta-analysis of familial prostate cancer risk. BJU International, 2003. 91(9): p. 789-794.
  13. Madersbacher, S., et al., The influence of family history on prostate cancer risk: implications for clinical management. BJU International, 2011. 107(5): p. 716-721.
  14. Cancer Council Australia. National Cancer Prevention Policy. 2013; Available from: http://wiki.cancer.org.au/prevention/National_Cancer_Prevention_Policy.
  15. Chen, Y.-C., et al., Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. The Prostate, 2008. 68(14): p. 1582-1591.
  16. Wei, E.K., K.Y. Wolin, and G.A. Colditz, Time Course of Risk Factors in Cancer Etiology and Progression. Journal of Clinical Oncology, 2010. 28(26): p. 4052-4057.
  17. Meyerhardt, J.A., J. Ma, and K.S. Courneya, Energetics in Colorectal and Prostate Cancer. Journal of Clinical Oncology, 2010. 28(26): p. 4066-4073.
  18. Ilic, D., et al., Screening for prostate cancer. Cochrane Database of Systematic Reviews 2006(3).
  19. Australian Government & National Health and Medical Research Council. PSA Testing or Prostate Cancer in Asymptomatic Men. Information for Health Practitioners. 2014 August 2014; Available from: https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/men4d_psa_testing_asymptomatic_men_140304.pdf (PDF, 121KB)
  20. Andrology Australia. Factsheet: PSA Testing. 2013 August 2014; Available from: https://www.andrologyaustralia.org/wp-content/uploads/Factsheet_PSA-Test.pdf (PDF, 389KB)
  21. Cancer Council Australia. Prostate cancer screening. 2008  27.04.2011.
  22. Victorian Government Department of Human Services. Patient management framework. Genitourinary tumour stream: prostate cancer. 2006 May 2015; Available from: http://www2.health.vic.gov.au/getfile//?sc_itemid=%7bC5BD0EFE-505A-41BC-8215-41780BB591C0%7d.
  23. Cancer Council Australia, et al. The early detection of prostate cancer in general practice: Referral guide for prostate testing. 2009  May 2015; Available from: http://www.cancervic.org.au/downloads/cpc/gps/prostate_showcard.pdf (PDF, 386KB)
  24. Rashid, P. and V. Marshall, Prostate cancer: your guide to the disease, treatment options and outcomes. 3rd edition ed. 2010, Port Macquarie, N.S.W.: Uronorth Group.
  25. Templeton, H., Prostate cancer – presentation, diagnosis and treatment: what does the literature say? International Journal of Urological Nursing, 2007. 1(1): p. 6-17.
  26. Australian Prostate Cancer Collaboration. Localised prostate cancer: a guide for men and their families. 2010  May 2015; Available from: https://www.andrologyaustralia.org/wp-content/uploads/BL-Localised-Prostate-Guide-2010-web-version.pdf (PDF, 1.91MB)
  27. Roethke, S.K., Initial assessment and diagnosis, in Contemporary issues in prostate cancer: a nursing perspective, Held-Warmkessel, Editor. 2006, Jones and Bartlett Paublishers: Sudbury, MA.
  28. Dimmen, M., et al., Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies. BJU International, 2012. 110(2b): p. E69-E75.
  29. Turner, B., Diagnosis and treatment of patients with prostate cancer: the nurse's role. Nursing Standard, 2007. 21(39): p. 48-56.
  30. Andrology Australia. Prostate cancer diagnosis. Factsheet. 2010 May 2014; Available from: https://www.andrologyaustralia.org/wp-content/uploads/Factsheet_ProstateCancerDiagnosis.pdf (PDF, 317KB)
  31. European Association of Urology. Guidelines on Prostate Cancer. 2014 May 2015; Available from: http://uroweb.org/wp-content/uploads/1607-Prostate-Cancer_LRV3.pdf (PDF, 709KB)
  32. Cash, J., Cellular characteristics, pathophysiology and disease manifestations, in Contemporary issues in prostate cancer: a nursing perspective, J. Held-Warmkessel, Editor. 2006, Jones and Bartlett Paublishers: Sudbury, MA.
  33. Humphrey, P.A., Histological variants of prostatic carcinoma and their significance. Histopathology, 2012. 60: p. 59-74.
  34. Epstein, J.I., An Update of the Gleason Grading System. The Journal of Urology, 2010. 183: p. 433-440.
  35. Egevad, L., R. Mazzucchelli, and R. Montironi, Implications of the International Society of Urological Pathology Modified Gleason Grading System. Archives of Pathology & Laboratory Medicine, 2012. 136(4): p. 426-434.
  36. Collins, M., Staging of prostate cancer, in Contemporary issues in prostate cancer: a nursing perspective, J. Held-Warmkessel, Editor. 2006, Jones and Bartlett Paublishers: Sudbury, MA.
  37. Stark, J.R., et al., Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3? Journal of Clinical Oncology, 2009. 27(21): p. 3459-3464.
  38. American Joint Committee on Cancer. Prostate Cancer Staging. 7th Edition. 2009 August 2014; Available from: https://cancerstaging.org/references-tools/quickreferences/Documents/ProstateSmall.pdf. (PDF, 1.01MB)
  39. Cookson, M.S. and I. Thompson, Reviewing the updated AUA prostate cancer guidelines. Contemporary Urology, 2007. 19(8): p. 9-19.
  40. 40.    National Comprehensive Cancer Network (NCCN), NCCN Clinical Practice Guidelines in Oncology: prostate cancer, version 2 2011 2011.
  41. Ellsworth, P., 100 questions and answers about prostate cancer. 2nd ed., Sudbury, MA: Jones and Bartlett
  42. Ferrer, M., et al., Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics, 2008. 72(2): p. 421-432.
  43. Hudak, J.L., et al., The design and implementation of a multidisciplinary prostate cancer clinic. Urologic Nursing, 2007. 27(6): p. 491-8.
  44. National Health and Medical Research Council and Australian Cancer Network, Clinical practice guidelines: evidence-based information and recommendations for the management of lacalised prostate cancer, in A report of the Australian Cancer Network Working Party on management of localised prostate cancer. 2003, Commonwealth of Australia.
  45. Garzotto, M. and A. Hung, Contemporary Management of High-risk Localized Prostate Cancer. Current Urology Reports, 2010. 11(3): p. 159-164.
  46. Ahmed, H.U., et al., Will focal therapy become a standard of care for men with localized prostate cancer? Nature Clinical Practice Oncology, 2007. 4(11).
  47. Duchesne, G., Localised prostate cancer. Current treatment options. Australian Family Physician, 2011. 40(10): p. 768-771.
  48. Klotz, L., et al., Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer. Journal of Clinical Oncology, 2010. 28(1): p. 126-131.
  49. Adamis, S. and I.M. Varkarakis, Defining prostate cancer risk after radical prostatectomy. European Journal of Surgical Oncology (EJSO), 2014. 40(5): p. 496-504
  50. Andrology Australia. Prostate cancer treatment. Factsheet. 2014 July 2014; Available from: https://www.andrologyaustralia.org/wp-content/uploads/Factsheet_ProstateCancerTreatment.pdf (PDF, 389KB)
  51. Fleissig, A.J., et al., Multidisciplinary teams in cancer care: are they effective in the UK? The Lancet Oncology, 2006. 7(11): p. 935-943.
  52. Sykes, J., Practice framework and competency standards for the Prostate Cancer Specialist Nurse. 2013, Prostate Cancer Foundation of Australia: Sydney.
  53. Australian Cancer Network Managment of Metastatic Prostate Cancer Working Party, Clinical Practice Guidelines for the Management of Locally Advanced and Metastatic Prostate Cancer. 2010, Cancer Council Australia and Australian Cancer Network: Sydney.
  54. Sooriakumaran, P., et al., Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. British Medical Journal, 2014. 348.
  55. Rondorf-Klym, L.M. and J. Colling, Quality of life after radical prostatectomy. Oncology Nursing Forum, 2003. 30(2): p. 24-32.
  56. Starnes, D.N. and T.W. Sims, Care of the patient undergoing robotic-assisted prostatectomy. Urologic Nursing, 2006. 26(2): p. 129-37.
  57. Thompson, I., et al., Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update. The Journal of Urology, 2007. 177(6): p. 2106-2131.
  58. Continence Foundation of Australia. Continence and prostate: a guide for men undergoing prostate surgery. 27.01.2018.
  59. Cotter, S.E., et al., Salvage radiation in men after prostate-specific antigen failure and the risk of death. Cancer, 2011: p. n/a-n/a.
  60. Treiyer, A., et al., A Single Center Prospective Study: Prediction of Postoperative General Quality of Life, Potency and Continence After Radical Retropubic Prostatectomy. The Journal of Urology, 2011. 185(5): p. 1681-1685.
  61. Continence Foundation of Australia. Pelvic floor muscle training for men. ND; Available from: http://www.pelvicfloorfirst.org.au/data/files/Pelvic_Floor_First/05_pelvic_floor_muscle_training_for_men1.pdf (PDF, 394KB)
  62. Continence Foundation of Australia. Pelvic floor first. 2013  August 2014; Available from: http://www.pelvicfloorfirst.org.au/.
  63. National Comprehensive Cancer Network. NCCN Guidelines Version 2.2014. Prostate Cancer. 2014 August 2014; Available from: http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.
  64. Strief, D.M., An overview of prostate cancer: diagnosis and treatment. Urologic Nursing, 2007. 27(6): p. 475-9.
  65. Crook, J., The role of brachytherapy in the definitive management of prostate cancer. Cancer/Radiothérapie, 2011. 15(3): p. 230-237.
  66. Cash, J., Interstitial Brachytherapy, in Contemporary issues in prostate cancer, J. Held-Warmkessel, Editor. 2006, Jones and Bartlett: Sudbury, MA. p. 229-247.
  67. Witt, M.E., et al., Understanding stereotactic radiosurgery for intracranial tumours, seed implants for prostate cancer and intravascular brachytherapy for cardiac restenosis. Cancer Nursing, 2003. 26(6): p. 494-502.
  68. Abbas, F. and P.T. Scardino, The natural history of clinical prostate carcinoma. Cancer, 1997. 80(5): p. 827-833.
  69. Akbal, C., et al., Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment. International Urology and Nephrology, 2008. 40(2): p. 355-63.
  70. National Collaborating Centre for Cancer, Prostate cancer: diagnosis and treatment, in NICE clinical guideline; no. 58. 2008, National Institute for Health and Clinical Excellence (NICE): London.
  71. National Cancer Institute. Prostate cancer treatment (PDQ). 2008  28.04.2011; Available from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page1.
  72. Kantoff, P.W., et al., Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. New England Journal of Medicine, 2010. 363(5): p. 411-422.
  73. National Breast Cancer Centre and National Cancer Control Initiative, Clinical practice guidelines for the psychosocial care of adults with cancer. 2003, National Breast Cancer Centre: Camperdown, NSW.
  74. Weber, B.A. and P. Sherwill-Navarro, Psychosocial consequences of prostate cancer: 30 years of research. Geriatric Nursing, 2005. 26(3): p. 166-75.
  75. Australian Cancer Survivorship Centre. Cancer Survivorship. 2010; Available from: https://www.petermac.org/sites/default/files/media-uploads/ACSC_HP_FactSheet_Survivorship_Care_Plan_WEB.pdf
  76. Peter MacCallam Cancer Centre, Navigate: An Online Treatment Decision Aid for Men Diagnosed with Prostate Cancer and their partners.  29.01.2018; Available from:https://www.petermac.org/research/clinical-research-trials/clinical-research/cancer-experiences-research/navigate-online​
  77. beyond blue and Prostate Cancer Foundation of Australia. Maintaining your well-being: Information on depression and anxiety for men with prostate cancer and their partners. 2009; 27.01.2018.
  78. beyond blue. Prostate cancer and the risk of depression / anxiety. 2011 May 2014; Available from: https://http://resources.beyondblue.org.au/prism/file?token=BL/0374 (PDF, 546KB)
  79. Krebs, L., What should I say? Talking with patients about sexuality issues. Oncology Nursing 2006. 10(3): p. 313-315.
  80. Albaugh, J.A., Addressing and managing erectile dysfunction after prostatectomy for prostate cancer. Urologic Nursing, 2010. 30(3): p. 167.
  81. Mazzola, C. and J.P. Mulhall, Penile Rehabilitation After Prostate Cancer Treatment: Outcomes and Practical Algorithm. Urologic Clinics of North America, 2011. 38(2): p. 105-118.
  82. Macmillan Cancer Care. Sexuality. 2009  28.04.2011; Available from: http://www.macmillan.org.uk/Cancerinformation/Livingwithandaftercancer/Relationshipscommunication/Sexuality/Sexuality.aspx.
  83. Cancer Council New South Wales. Sexuality, intimacy and cancer: a guide for people with cancer, their families and friends. 2013  May 2014; Available from: http://www.cancercouncil.com.au/wp-content/uploads/2013/07/CAN753-Sexuality-Intimacy-Cancer-NSW-LR.pdf (PDF, 435KB)
  84. Andrology Australia. Erectile Dysfunction (impotence). Factsheet. 2010 May 2014; Available from: https://www.andrologyaustralia.org/wp-content/uploads/Factsheet_Erectile-Dysfunction_2010.pdf (PDF, 68KB)
  85. Miles, C., et al., Interventions for sexual dysfunction following treatments for cancer. Cochrane Database of Systematic  Reviews, 2011(3).
  86. Australian Government and Cancer Australia. The psychosexual care of women affected by gynaecological cancers (PSGC) website home page. 2010  18.05.2011; Available from: http://modules.cancerlearning.gov.au/psgc/.
  87. Cancer Australia. Module 1: understanding sexuality. 2010  28.04.2011; Available from: http://modules.cancerlearning.gov.au/psgc/index.php?option=com_content&view=article&id=10&Itemid=19.
  88. Cancer Australia. Prostate Cancer Statistics. 2017. Available from: https://prostate-cancer.canceraustralia.gov.au/statistics
  • Copyright © 2021 - Cancer Australia
  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy